Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Corrigendum: Assessing National Biodiversity Trends for Rocky and Coral Reefs through the Integration of Citizen Science and Scientific Monitoring Programs.

Stuart-Smith RD, Edgar GJ, Barrett NS, Bates AE, Baker SC, Bax NJ, Becerro MA, Berkhout J, Blanchard JL, Brock DJ, Clark GF, Cooper AT, Davis TR, Day PB, Duffy JE, Holmes TH, Howe SA, Jordan A, Kininmonth S, Knott NA, Lefcheck JS, Ling SD, Parr A, Strain E, Sweatman H, Thomson R.

Bioscience. 2017 Aug 1;67(8):774. doi: 10.1093/biosci/bix070. Epub 2017 Jul 13.

2.

Assessing National Biodiversity Trends for Rocky and Coral Reefs through the Integration of Citizen Science and Scientific Monitoring Programs.

Stuart-Smith RD, Edgar GJ, Barrett NS, Bates AE, Baker SC, Bax NJ, Becerro MA, Berkhout J, Blanchard JL, Brock DJ, Clark GF, Cooper AT, Davis TR, Day PB, Duffy JE, Holmes TH, Howe SA, Jordan A, Kininmonth S, Knott NA, Lefcheck JS, Ling SD, Parr A, Strain E, Sweatman H, Thomson R.

Bioscience. 2017 Feb 1;67(2):134-146. doi: 10.1093/biosci/biw180. Erratum in: Bioscience. 2017 Aug 1;67(8):774.

3.

Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor.

Kreft A, Nelson J, Musser J, Failli A, Shah U, Kubrak D, Banker A, Steffan R, Schiehser G, Sturm R, et al.

Agents Actions. 1993;39 Spec No:C33-5.

PMID:
8273578
4.

Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugs.

Kreft AF, Failli AA, Musser JH, Kubrak DM, Banker AL, Steffan R, Demerson CA, Nelson JA, Shah US, Gray W, et al.

Drugs Exp Clin Res. 1991;17(8):381-7.

PMID:
1822830
5.

Supplemental Content

Loading ...
Support Center